Cargando…

Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients

Although salvage prostate bed radiotherapy is highly effective in biochemically-relapsing prostate cancer patients following prostatectomy, relapses remain frequent and improvements are needed. Randomized phase 3 trials have shown the benefit of adding androgen-depriving therapy to irradiation, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cailleteau, Axel, Sargos, Paul, Saad, Fred, Latorzeff, Igor, Supiot, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739777/ https://www.ncbi.nlm.nih.gov/pubmed/35004302 http://dx.doi.org/10.3389/fonc.2021.780507

Ejemplares similares

Delineation of the Prostate Bed: The “Invisible Target” Is Still an Issue?
por: Latorzeff, Igor, et al.
Publicado: (2017)

Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?
por: Giraud, Nicolas, et al.
Publicado: (2021)

Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review
por: Sargos, Paul, et al.
Publicado: (2021)

Editorial: Post Operative Radiation Treatment for Prostate Cancer
por: Latorzeff, I., et al.
Publicado: (2022)

Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept
por: Vilotte, Florent, et al.
Publicado: (2017)

PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
por: le Guevelou, Jennifer, et al.
Publicado: (2021)

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2017)

Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer Radiotherapy
por: Delpon, Grégory, et al.
Publicado: (2016)

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021)

Cytokine release syndrome and tumor lysis syndrome in a multiple myeloma patient treated with palliative radiotherapy: A case report and review of the literature
por: Cailleteau, Axel, et al.
Publicado: (2021)

Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients
por: Gonzalez-Moya, Ana, et al.
Publicado: (2022)

Preclinical Evaluation of Intraoperative Low-Energy Photon Radiotherapy Using Spherical Applicators in Locally Advanced Prostate Cancer
por: Buge, François, et al.
Publicado: (2015)

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
por: Rogé, Maximilien, et al.
Publicado: (2023)

Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?
por: Goineau, Aurore, et al.
Publicado: (2015)

The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy
por: Ah-Thiane, Loic, et al.
Publicado: (2023)

Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study
por: Latorzeff, Igor, et al.
Publicado: (2021)

Extramedullary hematopoiesis causing spinal cord compression in polycythemia vera: A case report and literature review
por: Cailleteau, Axel, et al.
Publicado: (2022)

Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysis
por: Goupy, Flora, et al.
Publicado: (2019)

Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study
por: Masson, Ingrid, et al.
Publicado: (2022)

Single-Center Experience of Focal Thermo-Ablative Therapy After Pelvic Radiotherapy for In-Field Prostate Cancer Oligo-Recurrence
por: Giraud, Nicolas, et al.
Publicado: (2021)

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2016)

Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP
por: Supiot, Stéphane, et al.
Publicado: (2018)

Targeting Local Recurrence After Surgery With MRI Imaging for Prostate Cancer in the Setting of Salvage Radiation Therapy
por: Renard-Penna, Raphaële, et al.
Publicado: (2022)

Complete biochemical response following metastasis-directed radiotherapy for oligometastatic prostate cancer: A case report
por: Okuda, Satoshi, et al.
Publicado: (2020)

Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life
por: Raziee, Hamid, et al.
Publicado: (2016)

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
por: Orré, Mathieu, et al.
Publicado: (2017)

Study of peripheral dose from low-dose CT to adaptive radiotherapy of postoperative prostate cancer
por: Gan, Guanghui, et al.
Publicado: (2023)

OLIGOPELVIS – GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer
por: Supiot, Stephane, et al.
Publicado: (2015)

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure
por: Katz, Alan, et al.
Publicado: (2016)

Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives
por: Detti, Beatrice, et al.
Publicado: (2022)

Sentinel Lymph Node Biopsy: A Great Opportunity for Personalized Radiotherapy in Prostate Cancer
por: Supiot, Stéphane, et al.
Publicado: (2023)

Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study
por: Kucharczyk, Michael Jonathan, et al.
Publicado: (2020)

FLASH Radiotherapy: History and Future
por: Lin, Binwei, et al.
Publicado: (2021)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy
por: Beck, Marcus, et al.
Publicado: (2016)

Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer
por: Spohn, Simon K.B., et al.
Publicado: (2022)

Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy
por: Sargos, Paul, et al.
Publicado: (2021)

Big Data Analytics for Prostate Radiotherapy
por: Coates, James, et al.
Publicado: (2016)

MR-Guided Radiotherapy for Prostate Cancer
por: Tocco, Boris R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_08eu9o167grn08fjsm70nhkmhe